Foaming Mold Uniform Cell Structure via Microcapsule Timing

The patent changes the foaming mechanism from chemical decomposition to physical thermal expansion. By using thermally expandable microcapsules that expand at a specific temperature range (above melting point but below decomposition temperature of the resin), the patent achieves reliable foaming without the decomposition issues of chemical agents. The microcapsules are designed to expand only under controlled thermal conditions during molding.

The patent introduces thermally expandable microcapsules as an intermediary between the resin and the foaming process. These microcapsules act as controlled gas sources that expand predictably under thermal stress, mediating the transformation from solid resin to foamed structure without the uncontrolled decomposition of chemical foaming agents.

The patent converts the harmful effect of rapid decomposition into a beneficial controlled expansion process. By using thermally expandable microcapsules that expand gradually at elevated temperatures, the patent eliminates the harmful residue and gas generation associated with chemical foaming agent decomposition, while still achieving the desired foaming volume.

The thermally expandable microcapsules serve as disposable gas sources that are consumed during the foaming process. Each microcapsule expands and ruptures to provide gas for cell formation, then is discarded, leaving no harmful residue. This approach replaces the problematic chemical foaming agents with clean, consumable microcapsules.

The patent changes the timing and control parameters of gas generation. By using thermally expandable microcapsules that expand after the resin has been injected and begun to cool, the patent ensures that gas is generated when the resin viscosity has increased enough to support cell wall formation. This temporal parameter change prevents cell wall tearing while achieving uniform closed-cell structure.

The patent performs preliminary resin injection and cooling before triggering the foaming action. By injecting the resin first and allowing it to cool and increase in viscosity, the patent creates a strong matrix that can support the subsequent gas expansion from microcapsules, preventing cell wall rupture and ensuring uniform closed-cell structure.

The patent maintains continuous useful action by overlapping the resin cooling process with the foaming process. Instead of separating cooling and foaming into distinct sequential steps, the patent allows foaming to occur during the cooling phase, eliminating idle time and maintaining productive action throughout the molding cycle.

The patent uses periodic thermal action to control the foaming process. By heating the resin to melt it for injection, then allowing it to cool to increase viscosity, and finally triggering microcapsule expansion during this cooling phase, the patent creates a periodic thermal cycle that optimizes both resin strength and foaming performance without extending the overall cycle time.

The patent optimizes multiple parameters simultaneously: microcapsule shell composition (nitrile-type monomer content), foaming agent content, heating temperature range, and die open timing. By adjusting these parameters, the patent achieves controlled expansion ratio, prevents surface foaming, eliminates distortion, and produces smooth surface finish while maintaining dimensional accuracy.

The patent creates different quality zones within the molded product. The skin layer near the mold cavity wall remains dense and non-foamed for smooth surface finish, while the interior core undergoes full foaming for lightweighting and insulation. This local differentiation of foaming quality resolves the contradiction between surface appearance and overall expansion ratio.